Stock Taper 
KEY STATISTICS
COMPANY
LEADERSHIP
ABOUT
PRICE
$0.54 ▲ UP 4.28% (+$0.02)About Gelteq Limited Ordinary Shares
https://www.gelteq.com ↗Gelteq Limited develops and commercializes gel-based delivery systems for humans and animals, offering white-label solutions for prescription drugs, OTC products, nutraceuticals, sports, and pet care, based in Caulfield, Australia.
INDUSTRY
A PRODUCT GELTEQ LIMITED ORDINARY SHARES IS KNOWN FOR
Gelteq provides a patented, gel-based oral drug delivery system as a white-label solution for companies in pharmaceuticals, nutraceuticals, and pet care to rebrand and customize.
Gelteq Limited Ordinary Shares in 2025
Gelteq Stock Surges Over 290% Following Breakthrough Drug Development Announcement
In April 2025, Gelteq Limited announced a significant breakthrough innovation within its pharmaceutical division, leading to a massive surge in investor confidence and a dramatic increase in the company's stock price. The news prompted analysts to revise their growth forecasts for the company and sparked speculation about potential future strategic partnerships.
Gelteq Validates Core Technology with Preclinical Trials Showing Significantly Enhanced Drug Bioavailability
Gelteq announced positive results from two separate preclinical studies for its proprietary gel-based oral delivery platform. The studies demonstrated a 38-45% increase in the bioavailability of a common antihistamine and a more than 20% improvement in overall absorption for oil-soluble compounds, validating the technology's potential to improve the efficacy of a wide range of drugs. [6, 9]
RATINGS SNAPSHOT
Overall rating: C-
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 AYTU | $2.11 | COMPARE |
 COCP | $1.15 | COMPARE |
 BFRI | $0.92 | COMPARE |
 BFRG | $0.62 | COMPARE |
 IMRN | $1.09 | COMPARE |
 IMNN | $1.29 | COMPARE |
 EVGN | $0.38 | COMPARE |
 BGLC | $1.28 | COMPARE |